Zobrazeno 1 - 10
of 20
pro vyhledávání: '"PAVAN, GARAPATI"'
Autor:
Pavan, Garapati, Kumar, Manish, Dhingra, Sameer, Kumar, Nitesh, V, Ravichandiran, Murti, Krishna
Publikováno v:
In Clinical Epidemiology and Global Health July-August 2024 28
Autor:
Udaya kumar, V., Pavan, Garapati, Murti, Krishna, Kumar, Rahul, Dhingra, Sameer, Haque, Mainul, Ravichandiran, V.
Publikováno v:
In Clinical Nutrition ESPEN December 2021 46:21-32
Publikováno v:
Journal of Patient-Reported Outcomes; 9/27/2024, Vol. 8 Issue 1, p1-8, 8p
Autor:
Devipriya J S, Ashok Kumar Gupta, Rajendra Babu Veeri, Pavan Garapati, Rishikesh Kumar, Sameer Dhingra, Krishna Murti, V Ravichandiran, Krishna Pandey
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256239 (2021)
BackgroundIn the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in p
Externí odkaz:
https://doaj.org/article/129593058485466c80ee11ba23eb9659
Autor:
A.S. Fathima, Vakada Lakshmi Mounika, V. Udaya Kumar, Ashok Kumar Gupta, Pavan Garapati, V. Ravichandiran, Sameer Dhingra, Krishna Murti
Publikováno v:
Health Sciences Review, Vol 1, Iss , Pp 100005- (2021)
With the upsurge in the cases of COVID-19 around the world, plenty of potential COVID-19 complications are becoming more prevalent, including a higher risk of secondary bacterial and fungal infections. Mucormycosis is one such condition which has hig
Externí odkaz:
https://doaj.org/article/352351760eeb4dd38239e5d841817b5a
Autor:
Varunraj Ponnala, Pavan Kumar Narapaka, Pavan Garapati, Gopal Vishwas, Adnan Imam, Sameer Dhingra
Publikováno v:
Current Pharmacology Reports.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dad85fcc815235ba854647117edf46f
https://doi.org/10.1007/s40495-023-00319-x
https://doi.org/10.1007/s40495-023-00319-x
Autor:
PAVAN, GARAPATI1, CHOUDHARY, KHUSHBOO2, PONNALA, VARUN RAJ1, VEERI, RAJENDRA BABU1, KUMAR, RAHUL1, CHATTU, VIJAY KUMAR3,4, MURTI, KRISHNA1 krishnamurti74@yahoo.co.in, DHINGRA, SAMEER1, RAVICHANDIRAN, V.1
Publikováno v:
International Journal of Pharmaceutical Research (09752366). Apr-Jun2021, Vol. 13 Issue 2, p3022-3027. 6p.
Autor:
Pavan Garapati, Biplab Pal, Niyamat Ali Siddiqui, Sanjiva Bimal, Pradeep Das, Krishna Murti, Krishna Pandey
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0203407 (2018)
BACKGROUND:Lesishmaniasis is a neglected tropical disease endemic in Bihar, India. Inappropriate health seeking behaviour of post kala-azar dermal leishmaniasis (PKDL) patients may increase the disease duration, severity and transmissibility. Simulta
Externí odkaz:
https://doaj.org/article/50a2a60edd004e2daa0bb769a608e756
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Krishna Murti, Sameer Dhingra, Krishna Pandey, Pavan Garapati, Rishikesh Kumar, Rajendra Babu Veeri, V. Ravichandiran, J S Devipriya, Ashok Kumar Gupta
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256239 (2021)
PLoS ONE
PLoS ONE
Background In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3415e74cb12d5a79ddb98630f8f3a7f0
https://doaj.org/article/129593058485466c80ee11ba23eb9659
https://doaj.org/article/129593058485466c80ee11ba23eb9659